Zobrazeno 1 - 10
of 93
pro vyhledávání: '"XiaoLong Jiao"'
Autor:
Tanios Bekaii-Saab, Nasreen Khan, Helene Ostojic, XiaoLong Jiao, Guifang Chen, Wenlong Lin, Amanda Bruno
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background The randomized, dose-optimization, open-label ReDOS study in US patients with metastatic colorectal cancer (CRC) showed that, compared with a standard dosing approach, initiating regorafenib at 80 mg/day and escalating to 160 mg/d
Externí odkaz:
https://doaj.org/article/53dbf12b07f5469a8c500d3b01838156
Autor:
Bin Li, Yabin Lu, Yaru Feng, Xiaolong Jiao, Qiuyu Zhang, Mengting Zhou, Yuyu Zhang, Jian Xu, Yuefeng Chu, Duoliang Ran
Publikováno v:
Pathogens, Vol 13, Iss 11, p 1003 (2024)
Mycoplasma bovis (M. bovis) is capable of causing pneumonia, arthritis, mastitis, and various other ailments in cattle of all age groups, posing a significant threat to the healthy progression of the worldwide cattle industry. The invasion of non-pha
Externí odkaz:
https://doaj.org/article/3a696e5d9a784ec7a990f0c9856dcc42
Publikováno v:
Journal of Materials Research and Technology, Vol 19, Iss , Pp 1678-1689 (2022)
Polyether-ether-ketone (PEEK) is an excellent engineering polymer with numerous advantages. Processing by microcellular injection molding (MIM) can reduce product weight and save energy consumption. However, conventional MIM is plagued with limited w
Externí odkaz:
https://doaj.org/article/136344565f1b4dfc8c92f9be9108b1e1
Autor:
John Bridgewater, Xiaolong Jiao, Mounika Parimi, Clare Flach, Jeran Stratford, Atanas Kamburov, Arndt A. Schmitz, Jihong Zong, John A. Reeves, Karen Keating, Amanda Bruno, Marc Fellous, Mariana Buongermino Pereira, Lyudmila Bazhenova
Publikováno v:
Cancer Treatment and Research Communications, Vol 33, Iss , Pp 100623- (2022)
Introduction: Neurotrophic tyrosine receptor kinase (NTRK) gene fusions are oncogenic drivers in various tumor types. Limited data exist on the overall survival (OS) of patients with tumors with NTRK gene fusions and on the co-occurrence of NTRK fusi
Externí odkaz:
https://doaj.org/article/9812c0175f7c49efba2bd73e1fd443b6
Publikováno v:
Discrete Dynamics in Nature and Society, Vol 2021 (2021)
Due to the limitation of later stage intelligent algorithms, the fruit and vegetable fresh-keeping cold chain transportation scheme did not meet the expectation and could not achieve the dual objectives of the shortest time and the lowest consumption
Externí odkaz:
https://doaj.org/article/36b3aa5b22634cfaae031581b77bd3ec
Publikováno v:
Discrete Dynamics in Nature and Society, Vol 2021 (2021)
Information sharing is the premise of the stable operation and win-win cooperation of the dual-channel agricultural supply chain. To arouse the enthusiasm of information sharing, this paper studies the incentive mechanism of information sharing of du
Externí odkaz:
https://doaj.org/article/5c568f4fa15d49e88c277733f348100b
Publikováno v:
Polymer Engineering & Science. 63:811-820
Autor:
Daniel J. George, Neeraj Agarwal, Oliver Sartor, Cora N. Sternberg, Bertrand Tombal, Fred Saad, Kurt Miller, Niculae Constantinovici, Helen Guo, John Reeves, XiaoLong Jiao, Per Sandström, Frank Verholen, Celestia S. Higano, Neal Shore
Publikováno v:
Prostate Cancer and Prostatic Diseases, Vol. 25, no. 2, p. 306-313 (2022)
Background The real-world EPIX study was conducted to gather information about the characteristics of patients with metastatic castration-resistant prostate cancer (mCRPC) who survived ≥2 years after treatment with the alpha-emitter radium-223. Met
Autor:
Yuxuan Xu, Pengcheng Xie, Nanhong Fu, Xiaolong Jiao, Jinling Wang, Gang Liu, Xiyu Dou, Yan Zha, Kaifang Dang, Weimin Yang
Publikováno v:
Polymer Engineering & Science. 62:1114-1123
Autor:
Kurt Miller, Cora N. Sternberg, Amanda Bruno, Helen Guo, Daniel J. George, XiaoLong Jiao, Bertrand Tombal, Neal D. Shore, Neeraj Agarwal, Per Sandstrom, Celestia S. Higano, Oliver Sartor, Fred Saad, Frank Verholen
Publikováno v:
Future Oncology. 18:35-45
Lay abstract Patients with metastatic castration-resistant prostate cancer are often first treated with novel hormonal therapy (NHT) using abiraterone or enzalutamide. To aid decisions about what treatment to use next, we reviewed information about p